Professor Andrew J Pollard
Professor Andrew J Pollard
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines
AJ Pollard, KP Perrett, PC Beverley
Nature Reviews Immunology 9 (3), 213, 2009
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization …
N Gossger, MD Snape, LM Yu, A Finn, G Bona, S Esposito, N Principi, ...
Jama 307 (6), 573-582, 2012
A CD8+ T cell transcription signature predicts prognosis in autoimmune disease
EF McKinney, PA Lyons, EJ Carr, JL Hollis, DRW Jayne, LC Willcocks, ...
Nature medicine 16 (5), 586, 2010
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles …
J Findlow, R Borrow, MD Snape, T Dawson, A Holland, TM John, A Evans, ...
Clinical Infectious Diseases 51 (10), 1127-1137, 2010
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial
MD Snape, KP Perrett, KJ Ford, TM John, D Pace, LM Yu, JM Langley, ...
Jama 299 (2), 173-184, 2008
Meningococcal disease: clinical presentation and sequelae
D Pace, AJ Pollard
Vaccine 30, B3-B9, 2012
Emergency management of meningococcal disease
AJ Pollard, J Britto, S Nadel, C DeMunter, P Habibi, M Levin
Archives of disease in childhood 80 (3), 290-296, 1999
Haemophilus influenzae type b conjugate vaccines
DF Kelly, ER Moxon, AJ Pollard
Immunology 113 (2), 163-174, 2004
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
RC Read, D Baxter, DR Chadwick, SN Faust, A Finn, SB Gordon, ...
The Lancet 384 (9960), 2123-2131, 2014
Meningococcal polysaccharide–protein conjugate vaccines
MD Snape, AJ Pollard
The Lancet infectious diseases 5 (1), 21-30, 2005
Vaccine prevention of meningococcal disease, coming soon?
SL Morley, AJ Pollard
Vaccine 20 (5-6), 666-687, 2001
Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial
MD Snape, T Dawson, P Oster, A Evans, TM John, B Ohene-Kena, ...
The Pediatric infectious disease journal 29 (11), e71-e79, 2010
Global epidemiology of meningococcal disease and vaccine efficacy
AJ Pollard
The Pediatric infectious disease journal 23 (12), S274-S279, 2004
Development of natural immunity to Neisseria meningitidis
AJ Pollard, C Frasch
Vaccine 19 (11-12), 1327-1346, 2001
Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells
EA Clutterbuck, R Lazarus, LM Yu, J Bowman, EAL Bateman, L Diggle, ...
Journal of Infectious Diseases 205 (9), 1408-1416, 2012
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label …
CS Waddington, WT Walker, C Oeser, A Reiner, T John, S Wilkins, ...
Bmj 340, c2649, 2010
Altitude illness
PW Barry, AJ Pollard
Bmj 326 (7395), 915-919, 2003
A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA
K Ewer, T Rampling, N Venkatraman, G Bowyer, D Wright, T Lambe, ...
New England Journal of Medicine 374 (17), 1635-1646, 2016
The epidemiology of meningococcal disease and the impact of vaccines
A Khatami, AJ Pollard
Expert review of vaccines 9 (3), 285-298, 2010
Safety and immunogenicity of novel adenovirus type 26–and modified vaccinia ankara–vectored ebola vaccines: a randomized clinical trial
ID Milligan, MM Gibani, R Sewell, EA Clutterbuck, D Campbell, E Plested, ...
Jama 315 (15), 1610-1623, 2016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20